Quantcast

Latest cancer detection Stories

2011-11-07 08:00:00

Oncimmune (USA) LLC recognizes Lung Cancer Awareness Month through a unique public awareness campaign. Oncimmune will feature 30 lung cancer stories from survivors and loved ones impacted by lung cancer on the HelloHaveYouHeard.com blog. De Soto, KS (PRWEB) November 07, 2011 Oncimmune (USA) LLC, maker of EarlyCDT®-Lung, a simple blood test that aids physicians in the early detection of lung cancer, is promoting Lung Cancer Awareness Month (LCAM) through an educational blog series. The...

2011-08-26 15:42:57

An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer. Syed Hashsham, a professor of civil and environmental engineering at MSU, is developing the Gene-Z device, which is operated using an iPod Touch or Android-based tablet and performs genetic analysis on microRNAs and other genetic markers. MicroRNAs are single-stranded...

2011-08-08 12:21:25

A new study supports the use of a DNA-based "biomarker" blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer. University of Cincinnati (UC) researchers report their findings online ahead of print in the British Journal of Cancer. Researchers conducted a meta-analysis of existing published data related to DNA methylation in bodily fluids. The goal was to evaluate a specific cancer biomarker"”known as GSTP1"”as a...

2011-07-25 00:00:28

Oncimmune, LLC announces the launch of a public awareness campaign designed to educated consumers about the importance of early lung cancer detection and the risk factors of lung cancer. De Soto, KS (PRWEB) July 25, 2011 Oncimmune® LLC, maker of EarlyCDTâ“ž¢-Lung, a simple blood test that aids physicians in the early detection of lung cancer, proudly announces the launch of a public awareness initiative designed to educate consumers about lung cancer...

2011-07-22 16:08:00

GERMANTOWN, Md., July 22, 2011 /PRNewswire/ -- RNL Natural Co., Ltd, a leading biotech company specialized in adult stem cell therapeutics affiliated with RNL BIO Co., Ltd., introduced on June 22, 2011 a new method of detecting breast cancer as early as at 'stage 0' through breath VOCs (volatile organic compounds, a predictor of breast cancer). Researchers at RNL conducted a study of 35 women diagnosed with breast cancer and 35 healthy women not suffering from the disease. These women...

2011-07-07 00:00:29

The results of a pilot study on lung cancer detection will be published in the prestigious Journal of Thoracic Oncology in July Vancouver, Canada (PRWEB) July 06, 2011 Verisante Technology, Inc. (TSX-V: VRS; OTCQX: VRSEF) (the "Company" or "Verisante") is pleased to announce that the results of a pilot study on lung cancer detection will be published in the prestigious Journal of Thoracic Oncology in July. The results of the pilot study indicate that the Company's system technology could...

2011-06-15 00:00:28

Verisante purchases endoscopy systems for early lung cancer detection to compliment Verisante Core Vancouver, Canada (PRWEB) June 13, 2011 Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the "Company" or "Verisante") announced today that the Company has entered into an Asset Purchase Agreement with Perceptronix Medical Inc. ("PMI"). Under the terms of the Agreement, Verisante has purchased all rights to the ClearVuâ“ž¢ and ClearVu...

2011-05-27 00:00:29

Verisante Technology Inc. lists on the OTCQX and completes Stage 1 Audit towards ISO Certification of Verisante Aura Vancouver, Canada (PRWEB) May 26, 2011 Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the "Company" or "Verisante") announced today that the Company will begin trading on the OTCQX International Tier as of the market opening on Thursday, May 26, 2011. The OTCQX International is the premier tier of the US OTC market, home to many of the world's largest companies by...

2011-05-04 07:00:00

SHELTON, Connecticut, May 4, 2011 /PRNewswire/ -- Women in the U.S. will now have the same opportunity as millions of European women already haveӚ­; to undergo mammography with a significantly lower radiation dose. This is the result of the U.S. Food and Drug Administration's (FDA) clearance of the Swedish IT and medical technology company Sectra's digital mammography system, Sectra MicroDose Mammography(TM) (http://www.sectra.com/pr-microdose)....


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.